ÂÜÀòÂÒÂ×

Colin Kegel is a seasoned financial professional with extensive experience in financial compliance and analysis. Currently, Colin serves as a Senior Consultant for Financial Compliance at Latham BioPharm Group since July 2022. Prior to this role, Colin held the position of Senior Financial Analyst at Battelle from December 2006 to July 2022. Colin began career at Northrop Grumman as a Financial Analyst from December 2004 to December 2006 and worked as a Project Control Analyst at SAIC from December 2002 to December 2004. Colin obtained a Bachelor of Science in Accounting from Mount St. Mary's University between 1998 and 2002 and holds a PMP certification.